Back
Intra-Cellular Therapies Stock Predictions
Sponsored
ITCI
Sponsored
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Buy
59
ITCI
Intra-Cellular Therapies
Last Price:
$127.22
Seasonality Move:
2.93%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]Intra-Cellular Therapies Stock Forecast
-
Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 35.8% based on the past 11 years of stock performance.
-
Intra-Cellular Therapies has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
-
Is Intra-Cellular Therapies Stock Undervalued?The current Intra-Cellular Therapies [ITCI] share price is $126.50. The Score for ITCI is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
ITCI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Intra-Cellular Therapies Stock Go Up Next Year?
-
Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 35.8% based on the past 11 years of stock performance.
Intra-Cellular Therapies Stock Rating
Buy
59
Intra-Cellular Therapies (ITCI)
is a Buy
Is Intra-Cellular Therapies overpriced?
-
Intra-Cellular Therapies has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
Intra-Cellular Therapies Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
intracellulartherapies.com
52-Week Data
52-Week High:
128.00
52-Week Low:
62.78
Prediction Charts
Market Cap:
13.4B
Price in USD:
126.50
Volume:
6.4M
Beta:
1.04
Technical Analysis
SMA50:
90.50
SMA100:
83.07
SMA200:
77.48
52-Wk Change:
93.28%
Stock Predictions
-
Is Intra-Cellular Therapies stock public?Yes, Intra-Cellular Therapies is a publicly traded company.
-
What is the Intra-Cellular Therapies stock quote today?The Intra-Cellular Therapies stock price is 126.50 USD today.
-
How to buy Intra-Cellular Therapies stock online?You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-30 | 84.21 | 83.48 | 84.86 | 82.32 |
Dec-31 | 83.67 | 83.52 | 84.70 | 83.05 |
Jan-2 | 84.16 | 84.24 | 84.99 | 83.75 |
Jan-3 | 84.59 | 83.72 | 84.64 | 82.76 |
Jan-6 | 83.71 | 81.78 | 83.76 | 81.40 |
Jan-7 | 81.68 | 83.23 | 84.19 | 80.83 |
Jan-8 | 83.00 | 82.56 | 83.05 | 81.86 |
Jan-10 | 86.53 | 94.87 | 98.40 | 86.25 |
Jan-13 | 127.95 | 127.19 | 128.00 | 126.90 |
Jan-14 | 127.19 | 126.89 | 127.45 | 126.75 |
Jan-15 | 126.91 | 126.71 | 127.16 | 126.00 |
Jan-16 | 127.00 | 126.26 | 127.09 | 126.25 |
Jan-17 | 126.65 | 126.20 | 126.74 | 126.16 |
Jan-21 | 126.64 | 126.50 | 126.93 | 126.43 |
Intra-Cellular Therapies Earnings
Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intra-Cellular Therapies Forecast Revenue Growth
Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $3.13 per share.
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.